View the content of this email online

AACR 2017: gene editing & immunotherapy using LentiFlash

LentiFlash™: RNA delivery into primary T cells for both gene editing and immunotherapy applications

Image NL AACR 2017
Separator

Two posters in the field of gene editing and immunotherapy have been shown by our experts at AACR 2017:

  • Gene editing: “Efficient KO of PD1 into primary T cells using a new non-integrative lentiviral particle expressing CRISPR/Cas9 system”
  • Immunotherapy: “Non-integrative lentiviral particles for immunotherapy: RNA delivery to drive tumoral antigen presentation in a safe and efficient way”

To have a look at each poster

Click Here

Follow us

Twitter Vectalys LinkedIn Vectalys Youtube Vectalys Google + Vectalys
www.vectalys.com
© Vectalys 2018

Click here to unsuscribe from the mailing list